Achievement of Endoscopic Remission After Induction Reduces Hospitalization Burden in Crohn's Disease: Findings From a Pooled Post Hoc Analysis of Risankizumab and Upadacitinib Phase III Trials.
Saved in:
| Title: | Achievement of Endoscopic Remission After Induction Reduces Hospitalization Burden in Crohn's Disease: Findings From a Pooled Post Hoc Analysis of Risankizumab and Upadacitinib Phase III Trials. |
|---|---|
| Authors: | Panaccione, Remo1 (AUTHOR), Ma, Christopher1,2 (AUTHOR), Jairath, Vipul2,3,4 (AUTHOR), Dignass, Axel5 (AUTHOR), Joshi, Namita6 (AUTHOR), Clark, Ryan6 (AUTHOR), Griffith, Jenny6 (AUTHOR), Kligys, Kristina6 (AUTHOR), Semwal, Monika6 (AUTHOR), Smith, Zachary7 (AUTHOR), Mitchell, Dominic7 (AUTHOR), Nunag, Dominic7 (AUTHOR), Ferrante, Marc8 (AUTHOR) |
| Source: | Journal of Crohn's & Colitis. Feb2025, Vol. 19 Issue 2, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 18739946 |
|---|---|
| DOI: | 10.1093/ecco-jcc/jjae128 |
